五月天堂婷婷爱,色狠狠天天综合色香阁,91免费看国产,久久久久成人精品亚洲国产av综合,91啦在线播放,免费a一级毛片在线播放,天天日日夜夜看综合网,亚洲成人国产精品,奇米影视7777狠狠狠狠色,日韩精品高清在线观看,福利久久久,久久99国产精品片久久99蜜桃,91香蕉视频网址,婷婷91,久久久久久臀欲欧美日韩,少妇丰满大乳被男人揉捏视频

In the United States, several agencies and organizations handle aspects of Clinical Trial Reports (CTR):

1. Food and Drug Administration (FDA)

• Role: The FDA is the primary regulatory body overseeing clinical trials for drugs, biologics, and medical devices. It reviews Clinical Trial Reports as part of regulatory submissions like New Drug Applications (NDAs), Biologics License Applications (BLAs), and Premarket Approval (PMA) applications.
• Website: FDA

2. Institutional Review Boards (IRBs)

• Role: IRBs review and approve clinical trial protocols and ensure the ethical conduct of trials. They are responsible for protecting participants' rights and welfare but are not directly involved in the handling of CTRs after the study is completed.
• Website: Office for Human Research Protections (OHRP)

3. National Institutes of Health (NIH)

• Role: The NIH supports and funds many clinical trials and requires the submission of study results for its funded research. It manages the ClinicalTrials.gov registry, where results and reports are often posted.
• Website: NIH

4. Centers for Medicare & Medicaid Services (CMS)

• Role: CMS may be involved in evaluating clinical trials that impact Medicare or Medicaid coverage. It is not directly involved in CTR handling but plays a role in assessing the relevance of trial results for healthcare coverage decisions.
• Website: CMS

5. Office for Human Research Protections (OHRP)

• Role: The OHRP oversees the protection of human subjects in research and provides guidance on ethical practices. It is involved in ensuring that trials comply with ethical standards but does not directly handle CTRs.
• Website: OHRP

These agencies and organizations collectively contribute to the oversight, approval, and dissemination of Clinical Trial Reports in the United States.